GHK has an extraordinarily high affinity for copper, and the biologically active form the chelated copper complex is what drives most of the peptides documented activity
Subcutaneous injection of 503A compounded GHK-Cu delivers the peptide into circulation, where it can reach target tissues throughout the body, including deeper dermal layers, hair follicles, and any tissue currently in a healing or remodeling phase
Full AI Image Prompt: Create a clean medical editorial infographic titled GHK-Cu Evidence Landscape. Design a vertical evidence ladder with five labeled rows: Topical photoaging, Diabetic ulcer wound studies, Skin permeation and formulation research, Hair growth models, and Injectable safety context. Add small columns or badges for Clinical or early human, Preclinical, and Regulatory safety context. Include neutral text snippets such as formulation matters, study context only, and not a guaranteed outcome. Use white background, clear typography, subtle blue, gray, and copper accents
Human clinical trials demonstrated that GHK-Cu creams significantly accelerated the healing of diabetic ulcers and surgical wounds
Visible results may begin within a few weeks, but optimal improvements occur with regular, long-term use